Announcement

Collapse
No announcement yet.

Feasibility of exergaming on patients undergoing HSCT

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Feasibility of exergaming on patients undergoing HSCT

    Not specific to MS, but a potentially interesting recovery tool. - D

    A prospective, randomized evaluation of the feasibility of exergaming on patients undergoing hematopoietic stem cell transplantation

    Helge Schumacher, Sabrina Stüwe, Peter Kropp, Doreen Diedrich, Sebastian Freitag, Nico Greger, Christian Junghanss, Mathias Freund & Inken Hilgendorf

    Bone Marrow Transplantation (2018)
    doi:10.1038/s41409-017-0070-8

    Published online:
    15 January 2018

    Abstract

    The positive effects of physical and sports therapy for strain dependent physical practice and improved quality of life (QoL) are well known. Nevertheless, the available capacities and problem-oriented therapies in the setting of hematopoietic stem cell transplantation (HSCT) are limited.

    We conducted a prospective, randomized study among 42 HSCT recipients in order to investigate the influence of exergaming on Nintendo WiiŪ or classical physiotherapy (PT) on physical fitness and psychological well-being. The trial included evaluation of muscle strength, endurance, physical activity, distress, QoL, anxiety, and depression.

    Within the first 2 weeks after HSCT endurance, muscle strength and physical well-being decreased, while the value of distress increased significantly in both groups. However, exergaming on Nintendo WiiŪ resulted in a decrease of anxiety and depression and improved emotional well-being, while the PT group showed a contrariwise pattern of these features.

    Analysis of the FACT-BMT revealed a decline of QoL domains 2 and 4 weeks after HSCT and an improvement afterwards. The decrease of functional status after HSCT was accompanied by a drop of QoL and an increase of distress in both groups. However, our prospective study demonstrates that exergaming using the Nintendo WiiŪ is feasible and well tolerated in HSCT recipients.
    Dave Bexfield
    ActiveMSers
Working...
X